Last reviewed · How we verify
NCT05908539
A Multi-level and Mixed-method Impact Evaluation for the Jockey Club Elders Get Active Fitness Campaign
NA trial testing Equipment box in Aging Well in 1,057 participants. Completed in 31 August 2025.
30 June 2024
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 1,057 |
| Start date | 2 January 2023 |
| Primary completion | 30 June 2024 |
| Estimated completion | 31 August 2025 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Equipment box
- Equipment box with briefing
- Exercise training
- Exercise training with behavioral modification
Conditions studied
- Aging Well — all drugs for Aging Well →
Sponsor
The University of Hong Kong
Who can join
60 and older, any sex, with Aging Well. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is provide a scientific evaluation on the impact of the Jockey Club Get Fitness Campaign to improve the physical capacity and health condition of the community-dwelling older adults after the COVID-19 pandemic. Participants will take part in any of the four care models: * a box of exercise equipment * a box of exercise equipment with verbal briefing * a box of exercise equipment and engage in the 8-week group-based exercise training * receive the wonderful box of exercise equipment and engage in the 8-week group-based exercise training together with the 6-week behavioral modification Participants with greater physical dependency, greater chronic disease burden or lower motivation for social engagement will take part in any of the three care models: * a box of exercise equipment only * a box of exercise equipment with verbal briefing * a box of exercise equipment and engage in the 4-session home-based exercise training, together with the 6-week behavioral modification
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05908539
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aging Well
Currently open trials in the same condition.
- NCT06507189 — Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX) · NA · recruiting
- NCT05910619 — Transcranial Pulse Stimulation of the Brain · NA · recruiting
- NCT06204562 — Feasibility and Effects of Laughter-imitation Therapy (LIT) · NA · active not recruiting
- NCT05920733 — Healthy Lifetime - Phase 2 · NA · recruiting
- NCT06217601 — Impact Evaluation of the Digital Connect Project for Homebound Older Adults · NA · active not recruiting
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05908539 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 17 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05908539.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing